| 文献: |
Tsuchida, H., Imai, G., Shima, Y., Satoh, T., Owada, S.
Mechanism of sodium load-induced hypertension in non-insulin dependent diabetes mellitus model rats: defective dopaminergic system to inhibit Na-K-ATPase activity in renal epithelial cells.
Hypertens Res 24:127-135, 2001
Schuller E., Patel,N., Item, C., Greber-Platzer, S., Baran, H., Patsch, W., Strobl W.
The genetic background modifies the effects of the obesity mutation, 'fatty', on apolipoprotein gene regulation in rat liver.
International Journal of Obesity & Related Metabolic Disorders. 24: 460-467, 2000
Tominaga, M.
Wistar fatty rat. [Review] [16 refs] [Japanese]
Nippon Rinsho - Japanese Journal of Clinical Medicine. 56 Suppl 3: 719-724, 1998
Yamatani, K., Ohnuma, H., Niijima, A., Igarashi, M., Sugiyama, K., Daimon, M., Manaka, H., Tominaga, M., Sasaki H.
Impaired vagus nerve-mediated control of insulin secretion in Wistar fatty rats.
Metabolism: Clinical & Experimental. 47: 1167-1173, 1998
Suzuki, H., Ikenaga, H., Hayashida, T., Otsuka, K., Kanno, Y., Ohno, Y., Ikeda, H., Saruta, T.
Sodium balance and hypertension in obese and fatty rats.
Kidney International - Supplement. 55: S150-153, 1996
Masuzaki, H., Hosoda, K., Ogawa, Y., Shigemoto, M., Satoh, N., Mori, K., Tamura, N., Nishi, S., Yoshimasa, Y., Yamori, Y., Nakao, K.
Augmented expression of obese (ob) gene during the process of obesity in genetically obese-hyperglycemic Wistar fatty (fa/fa) rats.
FEBS Letters. 378: 267-71, 1996
Hayakawa, T., Shiraki, T., Morimoto, T., Shii, K., Ikeda, H.
Pioglitazone improves insulin signaling defects in skeletal muscle from Wistar fatty (fa/fa) rats [published erratum appears in Biochem Biophys Res Commun 1997 Jul 30;236(3):833].
Bioch. Biophys. Res. Commun.. 223: 439-44, 1996
Yamakawa, T., Tanaka, S., Tamura, K., Isoda, F., Ukawa, K., Yamakura, Y., Takanashi, Y., Kiuchi, Y., Umemura, S., Ishiiu, M. et al.
Wistar fatty rat is obese and spontaneously hypertensive.
Hypertension. 25: 146-150, 1995
Oguchi, T. Tanaka, T.
Insulin resistance in obesity and its molecular control. [Review] [20 refs]
Obesity Research. 3 Suppl 2: 195S-198S, 1995
Noguchi, T., Matsuda, T., Tomari, Y., Yamada, K., Imai, E., Wang, Z., Ikeda, H., Tanaka, T.
The regulation of gene expression by insulin is differentially impaired in the liver of the genetically obese-hyperglycemic Wistar fatty rat.
FEBS Letters. 328: 145-148, 1993
Kava, RA., West, DB., Lukasik, VA., Wypijewski, C., Wojnar, Z., Johnson, PR., Greenwood, MR.
The effects of gonadectomy on glucose tolerance of genetically obese (fa/fa) rats: influence of sex and genetic background.
International Journal of Obesity & Related Metabolic Disorders. 16: 103-111, 1992
Jiao, S., Matsuzawa, Y., Matsubara, K., Kubo, M., Tokunaga, K., Odaka, H., Ikeda, H., Matsuo, T., Tarui, S.
Abnormalities of plasma lipoproteins in a new genetically obese rat withnon-insulin-dependent diabetes mellitus (Wistar fatty rat).
International Journal of Obesity. 15: 487-95, 1991
Kava, RA., West, DB., Lukasik, VA., Greenwood, MR.
Sexual dimorphism of hyperglycemia and glucose tolerance in Wistar fatty rats.
Diabetes. 38: 159-163, 1989
Seino, Y., Seino, S., Usami, M., Tsuda, K., Takemura, J., Nishi, S., Ishida, H., Imura, H.
Somatostatin, glucagon, and insulin secretion from isolated perfused pancreas of new genetically obese hyperglycemic rats.
Metabolism: Clinical & Experimental. 33: 429-431, 1984
Ikeda H, Shino A, Matsuo T, Iwatsuka H, Suzuoki Z
A new genetically obese-hyperglycemic rat (Wistar fatty).
Diabetes 30: 1045-1050, 1981 |